A Message to Our Community
Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the…
ADA’s Scientific Sessions: Day 4
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
University of Michigan Establishes Elizabeth Weiser Caswell Diabetes Institute
Named for Breakthrough T1D Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.
ADA’s Scientific Sessions: Day 3
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
Updates from the Teplizumab Trial: You’re Not Going to Believe the Results
Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for…
ADA’s Scientific Sessions: Day 2
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
ADA’s Scientific Sessions: Day 1
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
Breakthrough T1D Top Advances Over the Past Year
At Breakthrough T1D, we are committed to funding the development of new therapies to keep people with type 1 diabetes…
Breakthrough T1D Heads, Virtually, to ADA’s 80th Scientific Sessions
The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather,…
